Cytodyne sues New York Times
This article was originally published in The Tan Sheet
Executive Summary
Lawsuit filed in Newark, N. J. federal court June 24 by former Xenadrine marketer alleges New York Times reporter Ford Fessenden "selectively excluded scientific information regarding clinical testing performed" on Xenadrine in June 23 article on dietary supplements. Complaint alleges Fessenden failed to contact Cytodyne for clarification and "accepted only a one-sided, inaccurate and untruthful version of the 'facts.'" Suit refers to recent controversy involving reporter Jayson Blair and alleges newspaper has "engaged in a pattern of failing to supervise its reporters and failing to check the accuracy and completeness" of stories. In response, Times says it is "confident" in the accuracy of its article, "which was based on court records and judicial decisions"...